Biosenic SA

Bone Therapeutics signs definitive subscription agreement for a maximum of EUR 5M convertible bonds facility with ABO

30 5 2022 22:00:00 提供 Nasdaq GlobeNewswire

Bone Therapeutics enters into exclusive reverse merger discussions with Medsenic

11 5 2022 22:00:00 提供 Nasdaq GlobeNewswire

Bone Therapeutics to host Annual General Meeting and Extraordinary General Meeting on 8 June 2022

08 5 2022 22:00:00 提供 Nasdaq GlobeNewswire

Bone Therapeutics announces 2021 full year results

28 4 2022 22:00:00 提供 Nasdaq GlobeNewswire

Bone Therapeutics Secures EUR 5 Million Financing

11 4 2022 22:00:00 提供 Nasdaq GlobeNewswire

Bone Therapeutics to strategically focus on lead cell therapy product ALLOB

28 3 2022 22:00:00 提供 Nasdaq GlobeNewswire

Bone Therapeutics SA: Transparency notification received from Nyenburgh Holding NV

22 3 2022 23:00:00 提供 Nasdaq GlobeNewswire

Bone Therapeutics provides fourth quarter 2021 business update and 2022 outlook

18 1 2022 22:00:00 提供 Nasdaq GlobeNewswire

Bone Therapeutics SA: Transparency notification received from S.R.I.W. SA and Sofipôle SA

22 12 2021 22:00:00 提供 Nasdaq GlobeNewswire

Bone Therapeutics SA: Transparency notification received from Nyenburgh Holding NV

09 12 2021 22:00:00 提供 Nasdaq GlobeNewswire

Bone Therapeutics SA: Information on the total number of voting rights and shares

08 12 2021 22:00:00 提供 Nasdaq GlobeNewswire

Bone Therapeutics announces closing of private placement

07 12 2021 22:00:00 提供 Nasdaq GlobeNewswire

Bone Therapeutics Successfully Raises EUR 3.3 Million in Private Placement

02 12 2021 22:00:00 提供 Nasdaq GlobeNewswire

Bone Therapeutics and Link Health sign a non-binding term sheet for the global rights of ALLOB

28 11 2021 22:00:00 提供 Nasdaq GlobeNewswire

Bone Therapeutics Provides Third Quarter 2021 Business Update

25 10 2021 22:00:00 提供 Nasdaq GlobeNewswire

Bone Therapeutics appoints Scientific Advisory Board for iMSC cell and gene therapy platform development

11 10 2021 22:00:00 提供 Nasdaq GlobeNewswire

Bone Therapeutics signs research partnership with Implant Therapeutics to access induced Pluripotent Stem Cells (iPSC)

27 9 2021 22:00:00 提供 Nasdaq GlobeNewswire

Bone Therapeutics appoints Lieve Creten as interim Chief Financial Officer

20 9 2021 22:00:00 提供 Nasdaq GlobeNewswire

Bone Therapeutics reports half year 2021 results

07 9 2021 22:00:00 提供 Nasdaq GlobeNewswire

Bone Therapeutics SA reacts to the press release issued by Hybrigenics

06 9 2021 22:00:00 提供 Nasdaq GlobeNewswire